CAI logo

Caris Life Sciences, Inc. (CAI) Shareholders equity

annual shareholders equity:

-$277.19M-$257.52M(-1309.47%)
December 1, 2024

Summary

  • As of today (August 26, 2025), CAI annual stockholders equity is -$277.19 million, with the most recent change of -$257.52 million (-1309.47%) on December 1, 2024.
  • During the last 3 years, CAI annual shareholders equity has risen by +$1.42 billion (+83.72%).
  • CAI annual shareholders equity is now -139.47% below its all-time high of $702.24 million, reached on December 31, 2020.

Performance

CAI Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCAIbalance sheet metrics

quarterly shareholders equity:

$452.90M+$806.66M(+228.03%)
June 1, 2025

Summary

  • As of today (August 26, 2025), CAI quarterly stockholders equity is $452.90 million, with the most recent change of +$806.66 million (+228.03%) on June 1, 2025.
  • CAI quarterly shareholders equity is now -43.44% below its all-time high of $800.72 million, reached on September 30, 2021.

Performance

CAI quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCAIbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

CAI Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-1309.5%-
3 y3 years+83.7%-
5 y5 years-140.0%-34.1%

CAI Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-139.5%+83.7%-43.4%+228.0%
5 y5-year-139.5%+83.7%-43.4%+228.0%
alltimeall time-139.5%+83.7%-43.4%+228.0%

CAI Shareholders equity History

DateAnnualQuarterly
Jun 2025
-
$452.90M(-228.0%)
Mar 2025
-
-$353.75M(-144.2%)
Dec 2024
-$277.19M(+1309.5%)
-
Dec 2023
-$19.67M(-98.8%)
-
Dec 2022
-$1.70B(-342.4%)
-
Sep 2021
-
$800.72M(+5.9%)
Jun 2021
-
$756.26M(+4.1%)
Mar 2021
-
$726.21M(+3.4%)
Dec 2020
$702.24M(+1.3%)
$702.24M(+0.5%)
Sep 2020
-
$699.03M(+1.7%)
Jun 2020
-
$687.47M(-0.4%)
Mar 2020
-
$690.15M(-0.4%)
Dec 2019
$693.24M(-1.1%)
-
Dec 2019
-
$693.24M(+1.1%)
Sep 2019
-
$685.99M(-0.9%)
Jun 2019
-
$692.19M(-1.7%)
Mar 2019
-
$704.31M(+0.5%)
Dec 2018
$701.13M(+24.3%)
$701.13M(+0.7%)
Sep 2018
-
$696.47M(+10.8%)
Jun 2018
-
$628.75M(+1.0%)
Mar 2018
-
$622.82M(+10.5%)
Dec 2017
$563.85M(+23.2%)
$563.85M(+13.1%)
Sep 2017
-
$498.53M(+4.0%)
Jun 2017
-
$479.56M(+3.2%)
Mar 2017
-
$464.82M(+1.6%)
Dec 2016
$457.50M(-0.4%)
$457.50M(-0.3%)
Sep 2016
-
$459.02M(-1.5%)
Jun 2016
-
$465.94M(+0.7%)
Mar 2016
-
$462.86M(+0.8%)
Dec 2015
$459.18M(+3.9%)
$459.18M(-3.3%)
Sep 2015
-
$474.79M(+0.3%)
Jun 2015
-
$473.17M(+3.1%)
Mar 2015
-
$458.93M(+3.8%)
Dec 2014
$442.12M
$442.12M(+3.6%)
DateAnnualQuarterly
Sep 2014
-
$426.69M(+0.7%)
Jun 2014
-
$423.72M(-1.3%)
Mar 2014
-
$429.31M(+3.6%)
Dec 2013
$414.53M(+19.5%)
$414.53M(+4.2%)
Sep 2013
-
$397.85M(+4.5%)
Jun 2013
-
$380.55M(+4.8%)
Mar 2013
-
$363.03M(+4.7%)
Dec 2012
$346.85M(+50.8%)
$346.85M(+25.1%)
Sep 2012
-
$277.19M(+6.8%)
Jun 2012
-
$259.63M(+5.8%)
Mar 2012
-
$245.51M(+6.7%)
Dec 2011
$230.04M(+28.1%)
$230.04M(+5.4%)
Sep 2011
-
$218.19M(+6.2%)
Jun 2011
-
$205.44M(+6.0%)
Mar 2011
-
$193.84M(+7.9%)
Dec 2010
$179.60M(+39.1%)
$179.60M(+22.2%)
Sep 2010
-
$146.97M(+8.4%)
Jun 2010
-
$135.52M(+3.3%)
Mar 2010
-
$131.23M(+1.7%)
Dec 2009
$129.10M(+13.5%)
$129.10M(+2.5%)
Sep 2009
-
$126.00M(+3.4%)
Jun 2009
-
$121.90M(+4.1%)
Mar 2009
-
$117.13M(+2.9%)
Dec 2008
$113.79M(-13.2%)
$113.79M(-28.2%)
Sep 2008
-
$158.57M(+10.5%)
Jun 2008
-
$143.54M(+4.9%)
Mar 2008
-
$136.87M(+4.4%)
Dec 2007
$131.15M(+372.5%)
$131.15M(+5.1%)
Sep 2007
-
$124.83M(+4.8%)
Jun 2007
-
$119.06M(+361.4%)
Mar 2007
-
$25.80M(-7.0%)
Dec 2006
$27.75M(-15.9%)
$27.75M
Dec 2005
$32.99M(+38.5%)
-
Dec 2004
$23.82M(+57.0%)
-
Dec 2003
$15.18M
-

FAQ

  • What is Caris Life Sciences, Inc. annual stockholders equity?
  • What is the all time high annual shareholders equity for Caris Life Sciences, Inc.?
  • What is Caris Life Sciences, Inc. annual shareholders equity year-on-year change?
  • What is Caris Life Sciences, Inc. quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Caris Life Sciences, Inc.?

What is Caris Life Sciences, Inc. annual stockholders equity?

The current annual shareholders equity of CAI is -$277.19M

What is the all time high annual shareholders equity for Caris Life Sciences, Inc.?

Caris Life Sciences, Inc. all-time high annual stockholders equity is $702.24M

What is Caris Life Sciences, Inc. annual shareholders equity year-on-year change?

Over the past year, CAI annual stockholders equity has changed by -$257.52M (-1309.47%)

What is Caris Life Sciences, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of CAI is $452.90M

What is the all time high quarterly shareholders equity for Caris Life Sciences, Inc.?

Caris Life Sciences, Inc. all-time high quarterly stockholders equity is $800.72M
On this page